Tempo Smart Button™

The Tempo Smart Button attaches to a Tempo™ prefilled insulin pen and wirelessly sends insulin dose-related data to the TempoSmartApp via Bluetooth® wireless technology.*

Automatically Detect, Record, and Store Insulin Dose-Related Data With the Tempo Smart Button*

Attaches to the top of a Tempo Pen™ prefilled with a Lilly insulin

The Tempo Smart Button with green light ring

Light ring indicates when the Tempo Smart Button is paired and when data is being transmitted

Transmits insulin dose-related data at the push of a button when paired with the TempoSmart App*

A dosing entry in the TempoSmart App

The TempoSmart App uses the insulin dose-related data to display the brand of insulin, dose amount, data, and time of dose

Stores dosing data for delayed transmission when the app isn’t within range*

The three-arrow recycling symbol

Can be reused for up to 8 months and attached to different Tempo Pens

  • *
    To transfer insulin dose-related data automatically, the Tempo Smart Button must be connected to the app and within 9 feet (3 meters) of the Bluetooth® enabled mobile device. Insulin dosing information can also be entered manually.
  • Lyumjev® (insulin lispro-aabc) injection 100 units/mL, BASAGLAR® (insulin glargine) injection 100 units/mL, or Humalog® (insulin lispro) injection 100 units/mL.
  • The Tempo Smart Button has an expected battery life of up to 8 months. This amount of time may vary based on patient use.

Lyumjev® (insulin lispro-aabc) injection 100 units/mL

Indication
Lyumjev is a rapid-acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.

Select Important Safety Information
Lyumjev is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to insulin lispro-aabc or any of the excipients in Lyumjev.

BASAGLAR® (insulin glargine) injection 100 units/mL

Indication
BASAGLAR® is a long-acting human insulin analog indicated to improve glycemic control in adults and pediatric patients with type 1 diabetes mellitus and in adults with type 2 diabetes mellitus.

Limitations of Use: BASAGLAR is not recommended for the treatment of diabetic ketoacidosis.

Select Important Safety Information
BASAGLAR is contraindicated during episodes of hypoglycemia, and in patients with hypersensitivity to insulin glargine or any of the excipients in BASAGLAR.

Humalog® (insulin lispro) injection 100 units/mL

Indication
Humalog is a rapid-acting human insulin analog indicated to improve glycemic control in adults and children with diabetes mellitus.

Select Important Safety Information
Humalog is contraindicated during episodes of hypoglycemia and in patients with hypersensitivity to insulin lispro or any of the excipients in Humalog.